Detalhe da pesquisa
1.
Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression.
Pharmaceuticals (Basel);
16(1)2022 Dec 26.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36678528
2.
Efficacy and Safety of Subcutaneous Esketamine in the Treatment of Suicidality in Major Depressive Disorder and Bipolar Depression.
Clin Drug Investig;
42(10): 865-873, 2022 Oct.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36044154
3.
Comparative effectiveness of esketamine in the treatment of anhedonia in bipolar and unipolar depression.
J Affect Disord;
278: 515-518, 2021 01 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33017679
4.
A Clinical Rationale for Assessing the Impact of Childhood Sexual Abuse on Adjunctive Subcutaneous Esketamine for Treatment-Resistant Depression.
Front Psychiatry;
12: 608499, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34483976
5.
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression.
Rev Psiquiatr Salud Ment (Engl Ed);
14(4): 212-217, 2021.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34861929
6.
Repeated subcutaneous esketamine for treatment-resistant depression: Impact of the degree of treatment resistance and anxiety comorbidity.
J Psychopharmacol;
35(2): 142-149, 2021 02.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33427015
7.
The probability of response after each subcutaneous injection of esketamine in treatment-resistant depression.
Rev Psiquiatr Salud Ment (Engl Ed);
2020 Oct 16.
Artigo
em Inglês, Espanhol
| MEDLINE
| ID: mdl-33075541
8.
Effects of subcutaneous esketamine on blood pressure and heart rate in treatment-resistant depression.
J Psychopharmacol;
34(10): 1155-1162, 2020 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32638662
9.
Efficacy and safety of adjunctive therapy using esketamine or racemic ketamine for adult treatment-resistant depression: A randomized, double-blind, non-inferiority study.
J Affect Disord;
264: 527-534, 2020 03 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31786030
10.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial.
Medicine (Baltimore);
97(38): e12414, 2018 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-30235716
11.
Comparative study of esketamine and racemic ketamine in treatment-resistant depression: Protocol for a non-inferiority clinical trial
Artigo
em Inglês
| Arca: Repositório institucional da Fiocruz
| ID: arc-30736